• Je něco špatně v tomto záznamu ?

Flubendazole induces mitotic catastrophe and senescence in colon cancer cells in vitro

V. Králová, V. Hanušová, E. Rudolf, K. Čáňová, L. Skálová,

. 2016 ; 68 (2) : 208-18. [pub] 20160104

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc17000690

OBJECTIVES: Flubendazole (FLU), a member of benzimidazole family of anthelmintic drugs, is able to inhibit proliferation of various cancer cells. The aim of present study was to elucidate the mechanisms of antiproliferative effect of FLU on colorectal cancer cells in vitro. METHODS: The effect of FLU on proliferation, microtubular network, DNA content, caspase activation and senescence induction was studied in SW480 and SW620 cell lines. KEY FINDINGS: Flubendazole significantly affected cell proliferation in a pattern typical for mitotic inhibitor. This was accompanied by decrease in cyclin D1 levels, increase in cyclin B1 levels, activation of caspase 2 and caspase 3/7 and PARP cleavage. Morphological observations revealed disruption of microtubular network, irregular mitotic spindles, formation of giant multinucleated cells and increase in nuclear area and DNA content. In SW620 cell line, 37.5% giant multinucleated cells induced by FLU treatment showed positivity for SA-β-galactosidase staining. Cell lines were able to recover from the treatment and this process was faster in SW480 cells. CONCLUSION: Flubendazole in low concentration temporarily inhibits cell proliferation and induces mitotic catastrophe and premature senescence in human colon cancer cells in vitro.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17000690
003      
CZ-PrNML
005      
20170119110819.0
007      
ta
008      
170103s2016 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/jphp.12503 $2 doi
024    7_
$a 10.1111/jphp.12503 $2 doi
035    __
$a (PubMed)26730435
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Králová, Věra $u Department of Medical Biology and Genetics, Faculty of Medicine, Charles University in Prague, Hradec Králové, Czech Republic.
245    10
$a Flubendazole induces mitotic catastrophe and senescence in colon cancer cells in vitro / $c V. Králová, V. Hanušová, E. Rudolf, K. Čáňová, L. Skálová,
520    9_
$a OBJECTIVES: Flubendazole (FLU), a member of benzimidazole family of anthelmintic drugs, is able to inhibit proliferation of various cancer cells. The aim of present study was to elucidate the mechanisms of antiproliferative effect of FLU on colorectal cancer cells in vitro. METHODS: The effect of FLU on proliferation, microtubular network, DNA content, caspase activation and senescence induction was studied in SW480 and SW620 cell lines. KEY FINDINGS: Flubendazole significantly affected cell proliferation in a pattern typical for mitotic inhibitor. This was accompanied by decrease in cyclin D1 levels, increase in cyclin B1 levels, activation of caspase 2 and caspase 3/7 and PARP cleavage. Morphological observations revealed disruption of microtubular network, irregular mitotic spindles, formation of giant multinucleated cells and increase in nuclear area and DNA content. In SW620 cell line, 37.5% giant multinucleated cells induced by FLU treatment showed positivity for SA-β-galactosidase staining. Cell lines were able to recover from the treatment and this process was faster in SW480 cells. CONCLUSION: Flubendazole in low concentration temporarily inhibits cell proliferation and induces mitotic catastrophe and premature senescence in human colon cancer cells in vitro.
650    _2
$a stárnutí buněk $x účinky léků $7 D016922
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a velikost buněčného jádra $x účinky léků $7 D053145
650    _2
$a proliferace buněk $x účinky léků $7 D049109
650    _2
$a obrovské buňky $x účinky léků $x ultrastruktura $7 D015726
650    _2
$a lidé $7 D006801
650    _2
$a mebendazol $x analogy a deriváty $x farmakologie $7 D008463
650    _2
$a mikrotubuly $x účinky léků $x ultrastruktura $7 D008870
650    _2
$a mitóza $x účinky léků $7 D008938
650    _2
$a aparát dělícího vřeténka $x účinky léků $x ultrastruktura $7 D008941
650    _2
$a tubulin $x metabolismus $7 D014404
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Hanušová, Veronika $u Department of Medical Biology and Genetics, Faculty of Medicine, Charles University in Prague, Hradec Králové, Czech Republic.
700    1_
$a Rudolf, Emil $u Department of Medical Biology and Genetics, Faculty of Medicine, Charles University in Prague, Hradec Králové, Czech Republic.
700    1_
$a Čáňová, Kristýna $u Department of Medical Biology and Genetics, Faculty of Medicine, Charles University in Prague, Hradec Králové, Czech Republic.
700    1_
$a Skálová, Lenka $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University in Prague, Hradec Králové, Czech Republic.
773    0_
$w MED00002901 $t The Journal of pharmacy and pharmacology $x 2042-7158 $g Roč. 68, č. 2 (2016), s. 208-18
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26730435 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170103 $b ABA008
991    __
$a 20170119110928 $b ABA008
999    __
$a ok $b bmc $g 1179830 $s 961257
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 68 $c 2 $d 208-18 $e 20160104 $i 2042-7158 $m Journal of pharmacy and pharmacology $n J Pharm Pharmacol $x MED00002901
LZP    __
$a Pubmed-20170103

Najít záznam

Citační ukazatele

    Možnosti archivace